The latest update is out from MustGrow Biologics ( (TSE:MGRO) ).
MustGrow Biologics Corp. has successfully closed a non-brokered private placement, raising $2,585,000 through the sale of units consisting of unsecured convertible debentures and common share purchase warrants. The funds will be utilized for inventory production of TerraSante, working capital, and general corporate purposes. The private placement also involved related party transactions, which are exempt from certain regulatory requirements due to their limited market impact.
More about MustGrow Biologics
MustGrow Biologics Corp. is a company operating in the agricultural biotechnology industry, focusing primarily on developing and commercializing natural biopesticides and biofertilizers. The company aims to provide sustainable solutions for crop protection and soil health, targeting the agriculture sector’s shift towards organic and environmentally friendly practices.
YTD Price Performance: 23.56%
Average Trading Volume: 2,394
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $55.81M
For detailed information about MGRO stock, go to TipRanks’ Stock Analysis page.